Oscar Health reported an EPS of -$1.24, missing the consensus estimate of -$0.84, and revenue of $2.81 billion, below the Zacks Consensus Estimate of $3.21 billion.
Oscar Health's financial metrics reveal a debt-to-equity ratio of 0.72 and a current ratio of 0.95, indicating moderate leverage and potential liquidity issues, respectively.
Oscar Health, Inc. (NYSE:OSCR) is a health insurance company that leverages technology to simplify healthcare. Despite its innovative approach, the company faces significant competition within the insurance industry. On February 10, 2026, Oscar Health disclosed its earnings, revealing an EPS of -$1.24, which fell short of the consensus estimate of -$0.84. The company's revenue was $2.81 billion, missing the Zacks Consensus Estimate of $3.21 billion. Despite the growth, the company struggled to meet Wall Street expectations, highlighting ongoing challenges.Oscar Health's EPS of -$1.24 marked a decline from the previous year's -$0.62 and was significantly below the consensus estimate of -$0.84. This resulted in an EPS surprise of -47.62%. The company has exceeded consensus EPS estimates three times in the past four quarters, but this quarter's results underscore the difficulties it faces.The health insurer is dealing with high utilization of medical services by its plan enrollees, impacting its financial performance. Despite these challenges, Oscar Health remains optimistic about achieving profitability within the year.
The company's price-to-sales ratio of 0.26 and enterprise value to sales ratio of 0.19 suggest a relatively low valuation compared to its sales.Oscar Health's financial metrics indicate some concerns. The debt-to-equity ratio of 0.72 suggests moderate leverage, while the current ratio of 0.95 indicates potential liquidity issues. The negative P/E ratio of -14.22 and earnings yield of -7.03% reflect ongoing losses. Despite these challenges, the company continues to focus on its growth and profitability goals.
